420 related articles for article (PubMed ID: 28098136)
1. Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations.
Li YY; Chung GT; Lui VW; To KF; Ma BB; Chow C; Woo JK; Yip KY; Seo J; Hui EP; Mak MK; Rusan M; Chau NG; Or YY; Law MH; Law PP; Liu ZW; Ngan HL; Hau PM; Verhoeft KR; Poon PH; Yoo SK; Shin JY; Lee SD; Lun SW; Jia L; Chan AW; Chan JY; Lai PB; Fung CY; Hung ST; Wang L; Chang AM; Chiosea SI; Hedberg ML; Tsao SW; van Hasselt AC; Chan AT; Grandis JR; Hammerman PS; Lo KW
Nat Commun; 2017 Jan; 8():14121. PubMed ID: 28098136
[TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
[TBL] [Abstract][Full Text] [Related]
3. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
5. Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma.
Zheng H; Dai W; Cheung AK; Ko JM; Kan R; Wong BW; Leong MM; Deng M; Kwok TC; Chan JY; Kwong DL; Lee AW; Ng WT; Ngan RK; Yau CC; Tung S; Lee VH; Lam KO; Kwan CK; Li WS; Yau S; Chan KW; Lung ML
Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11283-11288. PubMed ID: 27647909
[TBL] [Abstract][Full Text] [Related]
6. Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-κB axis during nasopharyngeal carcinoma development.
Liu Y; Gong P; Zhou N; Zhang J; He C; Wang S; Peng H
Biochem Biophys Res Commun; 2019 Jun; 514(1):127-133. PubMed ID: 31027734
[TBL] [Abstract][Full Text] [Related]
7. Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells.
Sung WW; Chu YC; Chen PR; Liao MH; Lee JW
Cancer Lett; 2016 Nov; 382(1):21-31. PubMed ID: 27567526
[TBL] [Abstract][Full Text] [Related]
8. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
Wasil LR; Wei L; Chang C; Lan L; Shair KH
J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
[TBL] [Abstract][Full Text] [Related]
9. LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma.
Cai TT; Ye SB; Liu YN; He J; Chen QY; Mai HQ; Zhang CX; Cui J; Zhang XS; Busson P; Zeng YX; Li J
PLoS Pathog; 2017 Jul; 13(7):e1006503. PubMed ID: 28732079
[TBL] [Abstract][Full Text] [Related]
10. Constitutive activation of the canonical NF-κB signaling pathway in EBV-associated gastric carcinoma.
Zhang Y; Liu W; Zhang W; Wang W; Song Y; Xiao H; Luo B
Virology; 2019 Jun; 532():1-10. PubMed ID: 30974373
[TBL] [Abstract][Full Text] [Related]
11. Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape.
Bruce JP; To KF; Lui VWY; Chung GTY; Chan YY; Tsang CM; Yip KY; Ma BBY; Woo JKS; Hui EP; Mak MKF; Lee SD; Chow C; Velapasamy S; Or YYY; Siu PK; El Ghamrasni S; Prokopec S; Wu M; Kwan JSH; Liu Y; Chan JYK; van Hasselt CA; Young LS; Dawson CW; Paterson IC; Yap LF; Tsao SW; Liu FF; Chan ATC; Pugh TJ; Lo KW
Nat Commun; 2021 Jul; 12(1):4193. PubMed ID: 34234122
[TBL] [Abstract][Full Text] [Related]
12. Translational genomics of nasopharyngeal cancer.
Tsang CM; Lui VWY; Bruce JP; Pugh TJ; Lo KW
Semin Cancer Biol; 2020 Apr; 61():84-100. PubMed ID: 31521748
[TBL] [Abstract][Full Text] [Related]
13. Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing.
Tu C; Zeng Z; Qi P; Li X; Guo C; Xiong F; Xiang B; Zhou M; Liao Q; Yu J; Li Y; Li X; Li G; Xiong W
Carcinogenesis; 2018 Dec; 39(12):1517-1528. PubMed ID: 30102338
[TBL] [Abstract][Full Text] [Related]
14. Rediscovery of NF-κB signaling in nasopharyngeal carcinoma: How genetic defects of NF-κB pathway interplay with EBV in driving oncogenesis?
Yi M; Cai J; Li J; Chen S; Zeng Z; Peng Q; Ban Y; Zhou Y; Li X; Xiong W; Li G; Xiang B
J Cell Physiol; 2018 Aug; 233(8):5537-5549. PubMed ID: 29266238
[TBL] [Abstract][Full Text] [Related]
15. Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.
Lo AK; Dawson CW; Young LS; Ko CW; Hau PM; Lo KW
J Pathol; 2015 Oct; 237(2):238-48. PubMed ID: 26096068
[TBL] [Abstract][Full Text] [Related]
16. LMP1 strain variants: biological and molecular properties.
Mainou BA; Raab-Traub N
J Virol; 2006 Jul; 80(13):6458-68. PubMed ID: 16775333
[TBL] [Abstract][Full Text] [Related]
17. Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.
Tao Y; Shi Y; Jia J; Jiang Y; Yang L; Cao Y
Expert Rev Mol Med; 2015 Aug; 17():e15. PubMed ID: 26282825
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-κB pathway.
Xu YJ; Zhou R; Zong JF; Lin WS; Tong S; Guo QJ; Lin C; Lin SJ; Chen YX; Chen MR; Chen HL; Ye YB; Pan JJ
Cancer Lett; 2019 Apr; 447():33-40. PubMed ID: 30684592
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of latent membrane protein 1 in patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
Tabata YHibi S; Teramura T; Kuriyama K; Yagi T; Todo S; Sawada T; Imashuku S
Leuk Lymphoma; 2000 Jul; 38(3-4):373-80. PubMed ID: 10830744
[TBL] [Abstract][Full Text] [Related]
20. SPLUNC1 reduces the inflammatory response of nasopharyngeal carcinoma cells infected with the EB virus by inhibiting the TLR9/NF-κB pathway.
Ou C; Sun Z; Zhang H; Xiong W; Ma J; Zhou M; Lu J; Zeng Z; Bo X; Chen P; Li G; Li X; Li X
Oncol Rep; 2015 Jun; 33(6):2779-88. PubMed ID: 25891128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
